ZNF320 include a range of compounds that enhance its activity through various biochemical pathways. Forskolin directly stimulates adenylyl cyclase, leading to an increase in intracellular cAMP levels, which can enhance the functional activity of ZNF320 by improving its binding affinity or enabling allosteric regulation. Similarly, IBMX works to sustain the activation of cAMP-dependent pathways by inhibiting phosphodiesterases, which normally degrade cAMP, thereby indirectly supporting the activation state of ZNF320. Epinephrine engages with adrenergic receptors, initiating a cascade that also raises cAMP levels and activates PKA, potentially leading to the phosphorylation and consequent activation of ZNF320. The cAMP analog dibutyryl-cAMP can cross cell membranes and activate the same cAMP-dependent pathways, possibly resulting in an upsurge in ZNF320 activity.
PMA, an activator of protein kinase C (PKC), can lead to the phosphorylation of ZNF320, which is a critical step towards its activation. This effect is complemented by bryostatin 1, which modulates PKC activity, possibly leading to downstream effects that activate ZNF320. In a similar vein, ionomycin elevates intracellular calcium levels, which may activate calcium-dependent kinases that could phosphorylate ZNF320, thus enhancing its activity. Anisomycin works by activating MAP kinase pathways, which could lead to the activation of ZNF320 by phosphorylating transcription factors and proteins that interact with ZNF320. The inhibition of serine/threonine phosphatases by calyculin A and okadaic acid can prevent the dephosphorylation of proteins, which would maintain ZNF320 in a phosphorylated, active state. Zaprinast, through its inhibition of phosphodiesterase type 5, raises cGMP levels that can indirectly stimulate the cAMP pathways, offering another route to activate ZNF320. In contrast, chelerythrine, although primarily known as a PKC inhibitor, can alter kinase substrate specificity and possibly lead to the atypical phosphorylation and activation of ZNF320, demonstrating the complexity of cellular signaling pathways and their impact on protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) inhibits phosphodiesterases, thereby preventing cAMP degradation, which sustains activation of cAMP-dependent pathways potentially enhancing ZNF320 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which may result in phosphorylation of ZNF320, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular Ca2+ levels, potentially leading to the activation of calcium-dependent kinases which could phosphorylate and thus activate ZNF320. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that can permeate cell membranes and activate cAMP-dependent pathways, which may enhance ZNF320 activation. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine activates adrenergic receptors, which can lead to increased cAMP and activation of PKA, potentially resulting in the phosphorylation and activation of ZNF320. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a PKC inhibitor which can also have an activating effect on certain substrates by altering the kinase's substrate specificity, potentially leading to activation of ZNF320 through atypical phosphorylation events. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is a serine/threonine phosphatase inhibitor which can lead to increased phosphorylation levels of proteins, potentially including ZNF320, thereby enhancing its functional activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates MAP kinase pathways, which could lead to the activation of transcription factors and other proteins that interact with ZNF320, resulting in its activation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A, which leads to increased phosphorylation and could result in the activation of ZNF320 through enhanced phosphorylation. | ||||||
Bryostatin 1 | 83314-01-6 | sc-201407 | 10 µg | $245.00 | 9 | |
Bryostatin 1 binds to and modulates PKC, which might lead to downstream phosphorylation and activation of ZNF320. | ||||||